Current Posts – 11 June 2014

No apologies for writing about statins – again. These are the biggest selling drugs of all time and we still don’t know for certain if, for healthy people, they are worth taking. Now a group of independent statin experts and senior doctors have published an open letter stating there should be no increase in prescribing because commercial interests have rendered existing data unreliable. The statin saga represents a serious failure of evidence based medicine as it is currently organised.

We’ve written a lot about statins because it affects so many people and there seems a serious gaps in the evidence that it is as safe and effective as the medical mainstream claims. Last week one of statins’ most eminent and aggressive supporters rode into battle, claiming that errors in articles about statins that claimed the side effects were higher than he believed, were badly flawed, dangerous and should be withdrawn. We don’t think this is how science should be done.

Alzheimer’s is one of the most feared disorders, caring for sufferers threatens to bankrupt the NHS and there is growing evidence that your risk is related to known life-style factors. So how many hundreds of millions are being spent to identify those at risk – there are tests already available – and putting them on programs to reduce it? None. In fact less than 2% of Alzheimer’s research goes on ways to improve prevention. Patrick Holford explains how to help yourself.

If you are not confused about statins you haven’t been paying attention. Following a HealthInsightUK post a couple of weeks ago on the hidden statin data, questions about how much we can trust official estimates of your risk of suffering side effects has become front page news. Some experts warn side effects are common and can be dangerous while a new study found them practically non-existent. Jerome Burne separates the facts from the fantasy.



Editor: Jerome Burne |

Latest posts by Editorial (see all)

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann